论文部分内容阅读
局部应用糖皮质激素治疗常年性鼻炎疗效好,全身副怍用小,尤其是二丙酸氯地米松(BDP)治疗过敏性常年性鼻炎疗效更明显。但长期使用会致鼻粘膜萎缩和霉菌生长。扑地松纳(budesonide)的药理性质与BDP相似。本文通过常年性鼻炎治疗中长期使用扑地松纳的临床及实验室观察来评价此药的安全性及有效性。常年性鼻炎的门诊患者使用扑地松纳气雾剂治疗1年。每日早、晚各一次,每日用药量400μg(每次每个鼻孔喷二下)。在试验开始及治疗后1、2、46、9及12月分别进行随访。试验结果表明在药物使用过程中患者的体重、血压、血液学、血生化等方面
Topical glucocorticoid treatment of perennial perennial good effect, systemic paraplegia with small, especially beclomethasone dipropionate (BDP) in the treatment of allergic perennial rhinitis more effective. However, long-term use will lead to nasal mucosal atrophy and mold growth. The pharmacological properties of budesonide are similar to those of BDP. This article through the perennial rhinitis treatment Pu Pu Song Sen clinical and laboratory evaluation to evaluate the safety and effectiveness of the drug. Outpatients with perennial rhinitis are treated with budesonide aerosol for 1 year. Daily morning and evening each time, the daily dose of 400μg (each nostril spray twice). Follow-up was performed at the beginning of the trial and at 1, 2, 46, 9 and 12 months after treatment. Test results show that in the course of drug use in patients with weight, blood pressure, hematology, blood biochemistry and so on